Military Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Industry Today.

Press releases published on July 2, 2026

Jul. 2, 2026

Reporting live from Gaza and the West Bank, senior sector officials – alongside global medical and human rights leaders

Indeterminate EIN Presswire

Jul. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Capital Power to release second quarter 2026 results on July 29

Indeterminate GlobeNewswire

Jul. 2, 2026

Range Announces Conference Call to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 2, 2026

Latin Metals Reports AGM Results

Indeterminate GlobeNewswire

Jul. 2, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jul. 2, 2026

Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire

Jul. 2, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

Indeterminate GlobeNewswire